Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment (Q37271829)

19 August 2017

1 reference

title

Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment (English)

1 reference

19 August 2017

1 reference

Eric D Hsi

1

1 reference

19 August 2017

publication date

1 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

49

1 reference

19 August 2017

issue

9

1 reference

19 August 2017

page(s)

1668-1680

1 reference

Hodgkin's disease: unfolding concepts concerning its nature, management and prognosis

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Aberrant rel/nfkb genes and activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

The role of cytokines in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

The role of interleukin 13 in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

The Clinical Significance of Cytokines and Soluble Forms of Membrane-Derived Activation Antigens in the Serum of Patients with Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Reed-Sternberg cells and the TNF family of receptors/ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Interleukin-2, interleukin-12, and interferon-gamma levels and risk of young adult Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Epstein--Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

TiA1 in advanced-stage classical Hodgkin's lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

The prognostic value of the expression of Bcl-2, p53 and LMP-1 in patients with Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

High numbers of active caspase 3-positive Reed-Sternberg cells in pretreatment biopsy specimens of patients with Hodgkin disease predict favorable clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Immunobiology and pathophysiology of Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Phenotype, genotype and clonality of Reed-Sternberg cells in nodular sclerosis Hodgkin's disease: results of a single-cell study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Prognostic Significance of T-Cell or Cytotoxic Molecules Phenotype in Classical Hodgkin’s Lymphoma: A Clinicopathologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

Elevated Serum Levels of IL-10 are Associated with Inferior Progression-Free Survival in Patients with Hodgkin's Disease Treated with Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

High serum levels of B-lymphocyte stimulator are associated with clinical?pathological features and outcome in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802163339

10.1080/10428190802163339

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference